Oral manifestation associated with avelumab by Kevin Chung, Annu Singh, Joseph M. Huryn, Cherry L. Estilo

Subjects: Get full text

Oral toxicities associated with immunotherapy and targeted therapy in cancer treatment by Michel Souza Sueira, Juliana Borges de Lima Dantas, Gabriela Botelho Martins, Daniela Maria Santana Leal, Juliana Santos de Jesus Azevedo, Manoela Carrera

Subjects: Get full text

Unusual gingival presentation following treatment with pembrolizumab by Annu Singh, Dennis Shem, Lori Martinez-Rubio, Joseph M. Huryn, SaeHee K. Yom, Cherry L. Estilo

Subjects: Get full text

Oral Immune-Related Adverse Events Associated with PD-1 Inhibitor Treatment: A Case Series by Daniele Pergolini, Andrea Botticelli, Roberta Fascetti, Federica Rocchetti, Alessio Cirillo, Gianluca Tenore, Gaspare Palaia, Antonella Polimeni, Umberto Romeo

Subjects: Get full text

Oral Toxicities Associated with Immune Checkpoint Inhibitors: Meta-Analyses of Clinical Trials by Akanksha Srivastava, Graciela M. Nogueras-Gonzalez, Yimin Geng, Jasdev Singh, Jeffrey N. Myers, Yisheng Li, Mark S. Chambers

Subjects: Get full text

Oral Adverse Events Following COVID-19 Vaccination: Analysis of VAERS Reports by Abanoub Riad, Ave Põld, Elham Kateeb, Elham Kateeb, Sameh Attia

Subjects: “…pharmacovigilance oral adverse events following COVID-19 vaccination 2…”
Get full text